NEW YORK (GenomeWeb) – Meridian Bioscience today reported that its first quarter revenues fell 2 percent year over year.

The company said revenues decreased to $47.2 million for the three months ended Dec. 31, 2015, from $48.0 million a year ago, missing analysts' consensus estimate of $48.6 million in revenues for the quarter.

However, the firm's net earnings for the quarter rose 13 percent to $8.9 million, or $.21 per share, compared to $7.9 million, or $.19 per share, for Q1 2015, and matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.